Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
For inflammatory bowel disease, mesalamine, corticosteroids, immunomodulators (azathioprine, methotrexate), and biologics (infliximab, adalimumab, vedolizumab, ustekinumab) all have Level 1 evidence from Phase III trials with thousands of patients
By End-User Channel, Retail and E-Commerce Holds the Highest Market Share Retail and e-commerce channels lead with 48% share in 2025, driven by strong digital penetration, influencer-led awareness, subscription programs, and easy access to antioxidant and performance-nutrition products
Regulates digestions: This regulation is directly tied to how quickly food moves from the stomach to the intestines
Clinically the first sign of deficiency is anaemia
US$ 27.97
US$ 22.22
US$ 28.22
US$ 23.07
US$ 27.00
